⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OKYO News
OKYO Pharma Limited Ordinary Shares
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
globenewswire.com
OKYO
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
globenewswire.com
OKYO
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
globenewswire.com
OKYO
OKYO Pharma Announces Successful Type C Meeting with the FDA
globenewswire.com
OKYO
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
globenewswire.com
OKYO
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
globenewswire.com
OKYO
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
globenewswire.com
OKYO
OKYO Pharma to Ring the Opening Bell at Nasdaq
globenewswire.com
OKYO
OKYO Pharma Announces Chairman and Founder Acquires Shares
globenewswire.com
OKYO
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
globenewswire.com
OKYO